Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-02

FDA Approved: CHORIONIC GONADOTROPIN — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Chorionic Gonadotropin submitted by Fresenius Kabi USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chorionic gonadotropin (human chorionic gonadotropin)

Snippet

SUPPL AP for CHORIONIC GONADOTROPIN (CHORIONIC GONADOTROPIN)